SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-015224
Filing Date
2013-02-27
Accepted
2013-02-27 17:28:53
Documents
5
Period of Report
2013-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-6116_18k.htm 8-K 62603
2 EX-4.1 a13-6116_1ex4d1.htm EX-4.1 330353
3 EX-10.1 a13-6116_1ex10d1.htm EX-10.1 14909
4 EX-10.2 a13-6116_1ex10d2.htm EX-10.2 9087
5 EX-99.1 a13-6116_1ex99d1.htm EX-99.1 15505
  Complete submission text file 0001104659-13-015224.txt   433901
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 13648069
SIC: 2834 Pharmaceutical Preparations